Is abatacept an effective treatment for patients with RA who do not respond to other anti-TNF treatments?
Taylor
Peter C
PC
Kennedy Institute of Rheumatology Division, Imperial College Faculty of Medicine, London, UK. peter.c.taylor@imperial.ac.uk
D000069594:Abatacept; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D004185:Disability Evaluation; D004351:Drug Resistance / Q000187:drug effects*; D006304:Health Status; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D012720:Severity of Illness Index; D017211:Treatment Failure; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D018796:Immunoconjugates; D014409:Tumor Necrosis Factor-alpha; D000069594:Abatacept